Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers

References

• Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-The-Art Review. J Am Coll Cardiol. 2020;76(14):1690–1702. doi:10.1016/j.jacc.2020.08.014
   PubMed Web of Science ®Google Scholar
• Thornton C, Dahlen H, Korda A, Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. Am J Obstet Gynecol. 2013;208(6):476e1–5. doi:10.1016/j.ajog.2013.02.042
   Web of Science ®Google Scholar
• Thornton C, Tooher J, Ogle R, von Dadelszen P, Makris A, Hennessy A. Benchmarking the Hypertensive Disorders of Pregnancy. Pregnancy Hypertens. 2016;6(4):279–284. doi:10.1016/j.preghy.2016.04.009
   Web of Science ®Google Scholar
• Rana S, Granger J, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges and perspecticves. Circ Res. 2019;124(7):1094–1112. doi:10.1161/CIRCRESAHA.118.313276
   PubMed Web of Science ®Google Scholar
• Brown MA, Kenny LC, Karumanchi SA, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310. doi:10.1016/j.preghy.2018.05.004
   PubMed Web of Science ®Google Scholar
• Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341–354. doi:10.1016/S0140-6736(20
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. ACOG Practice Bulletin No. 202: gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133(1):1. doi:10.1097/AOG.0000000000003018
   Web of Science ®Google Scholar
• Bouter AR, Duvekot JJ. Evaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia. Pregnancy Hypertens. 2020;19:206–211. doi:10.1016/j.preghy.2019.11.011
   PubMed Web of Science ®Google Scholar
• Lowe SABL, Lust K, McMahon LP, et al. SOMANZ: guideline for the management of hypertensive disorders of pregnancy. Australian N Zealand J. 2014;55:e1.
   Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999–1011. doi:10.1016/S0140-6736(15)00070-7
   PubMed Web of Science ®Google Scholar
• Kane SC. First trimester screening for pre-eclampsia. Obstet Med. 2016;9(3):106–112. doi:10.1177/1753495X16649074
   PubMed Web of Science ®Google Scholar
• Bokslag AVW, Mol B, de Groot C, de Groot CJM. Preeclampsia; short and long term consequences for the mother and the neonate. Early Hum Dev. 2016;102:47–50. doi:10.1016/j.earlhumdev.2016.09.007
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Campbell DM. The incidence of severe complications of preeclampsia. Hypertension Pregnancy. 2005;24(2):181–190. doi:10.1081/PRG-200059873
   PubMed Web of Science ®Google Scholar
• Williams D. Preeclampsia and long term mental health. Obsetric Med. 2012;5(3):98–104. doi:10.1258/om.2012.120013
   Google Scholar
• Muijsers HR, van de Hejden N, Maas OWH, Consider JE. Preeclampsia as a first cardiovascular event. Curr Cardiovasc Risk Rep. 2019;13:21. doi:10.1007/s12170-019-0614-0
   Web of Science ®Google Scholar
• Elder PS, Gulati G, Michos M. Identification of female-specific risk enhances throughout the lifespan of women to improve cardiovascular disease prevention. Am j Preventive Cardiol. 2020;2:100028. doi:10.1016/j.ajpc.2020.100028
   PubMedGoogle Scholar
• Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020;318(6):F1315–F1326. doi:10.1152/ajprenal.00071.2020
   PubMed Web of Science ®Google Scholar
• Benagiano M, Mancuso S, Brosens JJ, Benagiano G. Long-term consequences of placental vascular pathology on the maternal and offspring cardiovascular systems. Biomolecules. 2021;11(11):1625. doi:10.3390/biom11111625
   PubMed Web of Science ®Google Scholar
• Von Dadelszen P, Sawchuck D, Justus Hofmeyr G. PRE-EMPT(PRE-eclampsia-Eclampsia Monitoring, Prevention and Treatment): a low and middle income country initiative to reduce the global burden of maternal, fetal and infant death and disease related to pre-eclampsia. Pregnancy Hypertens. 2013;3(4):199–202. doi:10.1016/j.preghy.2013.06.002
   Web of Science ®Google Scholar
• Pea R, Dekker G, Chaouat G, Elliot MG, Scioscia M. High Incidence of early onset preeclampsia is probably the rule and not the exception worldwide. 20th anniversary of the Reunion workshop. A summary. J Reprod Immunol. 2019;133:30–36. doi:10.1016/j.jri.2019.05.003
   Web of Science ®Google Scholar
• Rodriguez A, Tuuli MG, Odibo AO. First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction. Clin Lab Med. 2016;36(2):331–351. doi:10.1016/j.cll.2016.01.007
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2S):S1071–S1097e2. doi:10.1016/j.ajog.2020.07.020
   Web of Science ®Google Scholar
• Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Sys Rev. 2019;2019:10. doi:10.1002/14651858.CD004659.pub3
   Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377(7):613–622. doi:10.1056/NEJMoa1704559
   PubMed Web of Science ®Google Scholar
• Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and meta analysis. Am J Obstet Gynecol. 2018;218(3):287–293 e1. doi:10.1016/j.ajog.2017.11.561
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2S):S1108–S1119. doi:10.1016/j.ajog.2020.08.045
   PubMed Web of Science ®Google Scholar
• Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993;329(17):1213–1218. doi:10.1056/NEJM199310213291701
   PubMed Web of Science ®Google Scholar
• Roberge SBE, Nicolaides K. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum haemorrhage. Am J Obstet Gynecol. 2018;218(5):483–489. doi:10.1016/j.ajog.2017.12.238
   PubMed Web of Science ®Google Scholar
• Hastie CTS, Wikström A, Sandström A, Hesselman S, Bergman L. Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population- based cohort study. Am J Obstet Gynecol. 2021;224(1):95.e1–95.e12. doi:10.1016/j.ajog.2020.07.023
   Web of Science ®Google Scholar
• Hofmeyr GJ, Lawrie TA, Atallah AN, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Sys Rev. 2018;10(10):CD001059. doi:10.1002/14651858.CD001059.pub5
   Web of Science ®Google Scholar
• Sea F, Fogacci F, Banach M. Vitamin D supplementation and inceident preeclampsia: a systematic review and meta-analysis of randomized clinial trials. Clin Nutrition. 2020;39:1742–1752. doi:10.1016/j.clnu.2019.08.015
   Web of Science ®Google Scholar
• WHO. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. WHO; 2021.
   Google Scholar
• Berghella V, Saccone G. Exercise in pregnancy! Am J Obstet Gynecol. 2017;216(4):335–337. doi:10.1016/j.ajog.2017.01.023
   PubMed Web of Science ®Google Scholar
• Rea B, Pelaez M, Cordero Y. Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am j Obstetrics Gynecol Glob Rep. 2016;214:649.e1–649.e8. doi:10.1016/j.ajog.2015.11.039
   Google Scholar
• Sandstrom A, Snowden JM, Hoijer J, Bottai M, Wikstrom AK. Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: a population based cohort study. PLoS One. 2019;14(11):e0225716. doi:10.1371/journal.pone.0225716
   Web of Science ®Google Scholar
• Tan MY, Wright D, Syngelaki A, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstetrics Gynecol. 2018;51(6):743–750. doi:10.1002/uog.19039
   PubMed Web of Science ®Google Scholar
• NIfHaCE. Hypertension in Pregnancy: Diagnosis and Management. NICE; 2019.
   Google Scholar
• Duckitt KH. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br Med J. 2005;330(03):565–567. doi:10.1136/bmj.38380.674340.E0
   Web of Science ®Google Scholar
• O’Gorman N, Wright D, Poon LC, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstetrics Gynecol. 2017;49(6):756–760. doi:10.1002/uog.17455
   PubMed Web of Science ®Google Scholar
• Vea B. Risk factors of pre-eclampsia/ eclampsia and its adverse outcomes in low and middle income countries: a secondary WHO analysis. PLoS One. 2014;9(3):e91198. doi:10.1371/journal.pone.0091198
   Web of Science ®Google Scholar
• Poon LCK, Chelemen N. Maternal risk factorts for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24:104–110. doi:10.1038/jhh.2009.45
   PubMed Web of Science ®Google Scholar
• Wright D, Wright A, Nicolaides KH. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol. 2020;223(1):12–23 e7. doi:10.1016/j.ajog.2019.11.1247
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103e1–103 e12. doi:10.1016/j.ajog.2015.08.034
   Web of Science ®Google Scholar
• Wright D, Tan MY, O’Gorman N, et al. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019;220(2):199e1–199 e13. doi:10.1016/j.ajog.2018.11.1087
   Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62e1–62 e10. doi:10.1016/j.ajog.2015.02.018
   Web of Science ®Google Scholar
• Vikraman SK, Elayedatt RA. Pre-eclampsia screening in the first trimester - preemptive action to prevent the peril. j Maternal Fetal Neonatal Med. 2020;1–9. doi:10.1080/14767058.2020.1767059
   Web of Science ®Google Scholar
• Johnson SLB, Kalafat E, Thilaganathan B, Khalil A. Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy: a Systematic Review and Meta-Analysis. Hypertension. 2020;76(1):157–166. doi:10.1161/HYPERTENSIONAHA.119.14627
   Web of Science ®Google Scholar
• Poon LC, Kametas NA, Valencia C, Chelemen T, Nicolaides KH. Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 11-13 weeks. Hypertension in Pregnancy. 2011;30(1):93–107. doi:10.3109/10641955.2010.484086
   PubMed Web of Science ®Google Scholar
• Cnossen JS, Vollebregt KC, de Vrieze N, et al. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ. 2008;336(7653):1117–1120. doi:10.1136/bmj.39540.522049.BE
   PubMed Web of Science ®Google Scholar
• Poon LCZN, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11-13 weeks’ gestation. Fetal Diagn Ther. 2012;31(1):42–48. doi:10.1159/000335366
   PubMed Web of Science ®Google Scholar
• Park HJ, Shim SS, Cha DH. Combined Screening for Early Detection of Pre-Eclampsia. Int J Mol Sci. 2015;16(8):17952–17974. doi:10.3390/ijms160817952
   PubMed Web of Science ®Google Scholar
• Reddy M, Springhall EA, Rolnik DL, da Silva Costa F. How to perform first trimester combined screening for pre-eclampsia. Australas J Ultrasound Med. 2018;21(4):191–197. doi:10.1002/ajum.12111
   Google Scholar
• Rolnik DL, da Silva Costa F, Sahota D, Hyett J, McLennan A. Quality assessment of uterine artery Doppler measurement in first-trimester combined screening for pre-eclampsia. Ultrasound Obstetrics Gynecol. 2019;53(2):245–250. doi:10.1002/uog.19116
   Web of Science ®Google Scholar
• Gallo DM, Poon LC, Akolekar R, Syngelaki A, Nicolaides KH. Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks’ gestation. Fetal Diagn Ther. 2013;34(4):241–247. doi:10.1159/000356171
   PubMed Web of Science ®Google Scholar
• Akolekar RZ, Poon E, Pepes LC, Nicolaides S. Maternal serum placental growth factor at 11+0 to 13+6 weeks gestation in the prediction of preeclampsia. Ultrasound Obstetrics Gynecol. 2008;32(6):732–739. doi:10.1002/uog.6244
   PubMed Web of Science ®Google Scholar
• Poon LCM, Valencia C, Plasencis W, Nicolaides W. First trimester maternal serrum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstetrics Gynecol. 2009;33:23–33. doi:10.1002/uog.6280
   PubMed Web of Science ®Google Scholar
• Prefumo F, Farina A. First-trimester screening for pre-eclampsia: time for reflection. Ultrasound Obstetrics Gynecol. 2017;50(5):662–663. doi:10.1002/uog.18893
   Web of Science ®Google Scholar
• O’Gorman N, Wright D, Poon LC, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstetrics Gynecol. 2017;49(6):751–755. doi:10.1002/uog.17399
   PubMed Web of Science ®Google Scholar
• Tan MY, Syngelaki A, Poon LC, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstetrics Gynecol. 2018;52(2):186–195. doi:10.1002/uog.19112
   PubMed Web of Science ®Google Scholar
• Khalil AL, State-of-The-Art Review B. Controversies in the management of twin pregnancy. Ultrasound Obstetrics Gynecol. 2021;57:888–902. doi:10.1002/uog.22181
   Web of Science ®Google Scholar
• Francisco C, Wright D, Benko Z, Syngelaki A, Nicolaides KH. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstetrics Gynecol. 2017;50(5):589–595. doi:10.1002/uog.17531
   PubMed Web of Science ®Google Scholar
• Cheng Y, Leung TY, Law LW, Ting YH, Law KM, Sahota DS. First trimester screening for pre-eclampsia in Chinese pregnancies: case-control study. BJOG. 2018;125(4):442–449. doi:10.1111/1471-0528.14970
   Web of Science ®Google Scholar
• Zhang J, Han L, Li W, et al. Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study. BMC Pregnancy Childbirth. 2019;19(1):304. doi:10.1186/s12884-019-2455-8
   Web of Science ®Google Scholar
• Chaemsaithong P, Pooh RK, Zheng M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221(6):650e1–650 e16. doi:10.1016/j.ajog.2019.09.041
   Web of Science ®Google Scholar
• Hu J, Gao J, Liu J, et al. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China. Ultrasound Obstetrics Gynecol. 2021;58(4):529–539. doi:10.1002/uog.23645
   Web of Science ®Google Scholar
• Orosz L, Orosz G, Veress L, et al. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary. J Biotechnol. 2019;300:11–19. doi:10.1016/j.jbiotec.2019.04.017
   Web of Science ®Google Scholar
• Mosimann B, Pfiffner C, Amylidi-Mohr S, Risch L, Surbek D, Raio L. First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm. Swiss Med Wkly. 2017;147:w14498. doi:10.4414/smw.2017.14498
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1–33. doi:10.1002/ijgo.12802
   PubMed Web of Science ®Google Scholar
• Dubon Garcia A, Devlieger R, Redekop K, Vandeweyer K, Verlohren S, Poon LC. Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium. Pregnancy Hypertens. 2021;25:219–224. doi:10.1016/j.preghy.2021.06.012
   Web of Science ®Google Scholar
• Guy GP, Leslie K, Diaz Gomez D, et al. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study. BJOG. 2021;128(2):149–156. doi:10.1111/1471-0528.16361
   Web of Science ®Google Scholar
• Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH. Two-stage screening for preterm preeclampsia at 11-13 weeks’ gestation. Am J Obstet Gynecol. 2019;220(2):197e1–197 e11. doi:10.1016/j.ajog.2018.10.092
   Web of Science ®Google Scholar
• Chitty L, Cameron L, Daley R. RAPID Non-invasive prenatal testing (NIPT) evaluation study Executive summary. Executive summary. UK NSC; 2015.
   Google Scholar
• Gynaecologists RCoOa. The Investigation and Management of the Small-for-Gestational-Age Fetus. Green-Top Guideline No. 2014;31:548.
   Google Scholar
• Goldenberg RJ, Griffin B, Rouse J. Reducing maternal mortality from preeclampsia and eclampsia in low resource countries- what should work? Acta Obstet Gynecol Scand. 2014;94(2):148–155. doi:10.1111/aogs.12533
   Web of Science ®Google Scholar
• Warren CH, Ishaku SMI, Armbruster S. A primary health care model for manageing pre-eclampsia and eclampsia in low and middle income countries. Reprod Health. 2020;17(1):46. doi:10.1186/s12978-020-0897-0
   Web of Science ®Google Scholar
• Hoffman MK, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285–293. doi:10.1016/S0140-6736(19)32973-3
   PubMed Web of Science ®Google Scholar
• Short VL, Metgud M. Safety of daily low-dose aspirin use during pregnancy in low-income and middle-income countries. Am J Obstet Gynecol. 2021;1:100003.
   Google Scholar
• De Oliveira LD, Prado ALD, Cunha Fihlo CAC. Pre-eclampsia: universal Screening or Universal Prevention for Low and Middle-Income Settings? Rev Bras Ginecol Obstet. 2021;43(1):61–65. doi:10.1055/s-0040-1713803
   PubMedGoogle Scholar
• Gynecologists ACoOa. Low Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality. Practive Advisory. 2021;1:548.
   Google Scholar
• ACOG. Committee Opinion No.743: low dose Aspirin Use During Pregnancy. Obstet Gynecol. 2018;132:e44–e52. doi:10.1097/AOG.0000000000002708
   PubMed Web of Science ®Google Scholar